U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. Public Meeting on the Reauthorization of the Generic Drug User Fee Amendments (GDUFA) - 07/21/2020 - 07/21/2020
  1. Drugs

Public | Virtual

Event Title
Public Meeting on the Reauthorization of the Generic Drug User Fee Amendments (GDUFA)
July 21, 2020

Date:
July 21, 2020

Meeting Information

The Food and Drug Administration (FDA or Agency) held a virtual public meeting to discuss the reauthorization of the Generic Drug User Fee Amendments (GDUFA) for fiscal years (FYs) 2023 through 2027 on July 21, 2020, from 9:00 a.m. to 3:00 p.m.  

Event Materials

Title File Type/Size
GDUFA III Public Meeting Agenda pdf (114.76 KB)
GDUFA III Public Meeting Transcript pdf (3.12 MB)
GDUFA III Public Meeting Presentations pdf (4.17 MB)
Back to Top